Current Assets

Current Equity Amortized Cost

Vertex Pharmaceuticals Current Equity Amortized Cost remained flat by 0.0% to $25.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 58.3%, from $60.00M to $25.00M. Over 5 years (FY 2020 to FY 2025), Current Equity Amortized Cost shows a downward trend with a -13.4% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2019
Last reportedQ1 2026May 5, 2026
Metric ID: current_equity_amortized_cost

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$51.43M$69.42M$69.40M$69.40M$69.40M$104.40M$104.40M$129.40M$72.10M$72.10M$72.10M$72.10M$72.10M$72.10M$72.10M$60.00M$60.00M$25.00M$25.00M$25.00M
QoQ Change—+35.0%-0.0%+0.0%+0.0%+50.4%+0.0%+23.9%-44.3%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%-16.8%+0.0%-58.3%+0.0%+0.0%
YoY Change————+34.9%+50.4%+50.4%+86.5%+3.9%-30.9%-30.9%-44.3%+0.0%+0.0%+0.0%-16.8%-16.8%-65.3%-65.3%-58.3%
Range$25.00M – $129.40M
CAGR-14.1%
Avg YoY Growth-6.4%
Median YoY Growth-8.4%
Current Streak2 quarters growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's current equity amortized cost?
Vertex Pharmaceuticals (VRTX) reported current equity amortized cost of $25.00M in Q1 2026.
How has Vertex Pharmaceuticals's current equity amortized cost changed year-over-year?
Vertex Pharmaceuticals's current equity amortized cost decreased by 58.3% year-over-year, from $60.00M to $25.00M.
What is the long-term trend for Vertex Pharmaceuticals's current equity amortized cost?
Over 5 years (2020 to 2025), Vertex Pharmaceuticals's current equity amortized cost has grown at a -13.4% compound annual growth rate (CAGR), from $51.43M to $25.00M.